Linagliptin

Results: 19



#Item
1C:�uments and Settings�yand�ktop�rmacists Bulletin July 2015.wpd

C:uments and Settingsyandktoprmacists Bulletin July 2015.wpd

Add to Reading List

Source URL: www.gov.pe.ca

Language: English - Date: 2015-07-21 08:29:01
2Trajentamet® Tablets linagliptin / metformin hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common

Trajentamet® Tablets linagliptin / metformin hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common

Add to Reading List

Source URL: files.boehringer.com.au

Language: English - Date: 2015-03-02 09:00:05
    3Re-Submission linagliptin 5mg tablet (Trajenta®) Boehringer Ingelheim and Eli Lilly SMC No)

    Re-Submission linagliptin 5mg tablet (Trajenta®) Boehringer Ingelheim and Eli Lilly SMC No)

    Add to Reading List

    Source URL: www.scottishmedicines.org.uk

    Language: English
      4Microsoft WordLinagliptin + Metformin Boerhinger PSD March 2013 FINAL.docx

      Microsoft WordLinagliptin + Metformin Boerhinger PSD March 2013 FINAL.docx

      Add to Reading List

      Source URL: www.pbs.gov.au

      Language: English - Date: 2014-10-01 21:56:23
      5most advertised brand Janssen blood thinner Xarelto seized most-advertised-brand honors with an outlay of just under $12 million—more than $4 million short of what last year’s most advertised brand, Forest anti-depre

      most advertised brand Janssen blood thinner Xarelto seized most-advertised-brand honors with an outlay of just under $12 million—more than $4 million short of what last year’s most advertised brand, Forest anti-depre

      Add to Reading List

      Source URL: media.mmm-online.com

      Language: English - Date: 2013-05-21 21:42:48
      6Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

      Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

      Add to Reading List

      Source URL: www.pmda.go.jp

      Language: English - Date: 2015-01-09 03:35:30
      7I S S U E # 7 3 • N ove m b e r[removed]w w w . d i a Tr i b e . o r g research and product news for people with diabetes

      I S S U E # 7 3 • N ove m b e r[removed]w w w . d i a Tr i b e . o r g research and product news for people with diabetes

      Add to Reading List

      Source URL: diatribe.org

      Language: English - Date: 2014-11-24 18:13:33
      8UTAH DEPARTMENT OF HEALTH, PRIOR AUTHORIZATION REQUEST FORM Dipeptidyl Peptidase IV (DPP-4) Inhibitors (alogliptin, linagliptin, saxagliptin, sitagliptin and combination products) Patient name:_________________________

      UTAH DEPARTMENT OF HEALTH, PRIOR AUTHORIZATION REQUEST FORM Dipeptidyl Peptidase IV (DPP-4) Inhibitors (alogliptin, linagliptin, saxagliptin, sitagliptin and combination products) Patient name:_________________________

      Add to Reading List

      Source URL: medicaid.utah.gov

      Language: English - Date: 2014-08-07 16:26:15
      9B.C. PharmaCare is a government-funded drug plan. It helps British Columbians with the cost of eligible prescription drugs and specific medical supplies. About PharmaCare

      B.C. PharmaCare is a government-funded drug plan. It helps British Columbians with the cost of eligible prescription drugs and specific medical supplies. About PharmaCare

      Add to Reading List

      Source URL: www.health.gov.bc.ca

      Language: English - Date: 2014-08-01 13:22:57
      10Information for Health Care Professionals Transitioning Patients to a Different Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Background Ten classes of antihyperglycemic medications are currently approved for use in type 2 d

      Information for Health Care Professionals Transitioning Patients to a Different Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Background Ten classes of antihyperglycemic medications are currently approved for use in type 2 d

      Add to Reading List

      Source URL: www.health.gov.bc.ca

      Language: English - Date: 2014-10-06 15:16:38